Synonyms: NN-2211 | NN2211 | NNC 90-1170 | NNC-90-1170 | Victoza®
liraglutide is an approved drug (EMA (2009), FDA (2010))
Compound class:
Peptide
Comment: Liraglutide is a synthetic analog of human GLP-1, with the addition of a palmitic acid moeity which acts to increase the drug's half-life and prolong its activity.
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖![]() View more information in the IUPHAR Pharmacology Education Project: liraglutide |
|
Peptide Sequence ![]() |
|
HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG | |
His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly |
Chemical Modification | |
Amide bridge formed between lysine residue at position 20 and a glutamamic acid residue |
Download 2D Structure ![]() |
|
Canonical SMILES | Download |
Isomeric SMILES | Download |
InChI standard identifier | Download |
InChI standard key | Download |
Molecular structure representations generated using Open Babel